Insmed Incorporated (NASDAQ:INSM) Q4 2025 earnings call transcript

Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript February 19, 2026 Insmed Incorporated misses on earnings ...
CNBCTV18

Zydus Life gets FDA nod for children’s lung treatment drug bosentan

Zydus Lifesciences Ltd received US FDA approval for bosentan tablets for oral suspension, 32 mg, for pulmonary arterial hypertension (PAH) treatment. Shares of Zydus Lifesciences Ltd ended marginally ...

Zydus Lifesciences shares in focus on final USFDA approval for Bosentan tablets

The approved product will be manufactured at the group’s formulation manufacturing facility located at SEZ, Ahmedabad.

Insmed Q4 Earnings Call Highlights

Insmed (NASDAQ:INSM) executives highlighted a strong 2025 and set an aggressive near-term outlook during the company’s fourth-quarter and full-year 2025 earnings call, pointing to an early “stunning” ...
Health.com

11 Bodyweight Core Exercises More Effective Than Sit-Ups

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Dead bugs improve core stability and coordination by ...